Last edition
News about " TELLOMAK-3 confirmatory Phase 3 study"
Sobi-Innate Pharma Partnership Advances Lacutamab Phase 3 Study
The partnership between Sobi and Innate Pharma will support the TELLOMAK-3 confirmatory Phase 3 trial in CTCL and development of lacutamab in Sézary syndrome.
TELLOMAK-3 Confirmatory Phase 3 Study | 18/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members